Welcome to our dedicated page for Castellum SEC filings (Ticker: CTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Castellum, Inc. (CTM) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Castellum is a Nevada corporation listed on the NYSE American that describes itself as a cybersecurity, electronic warfare, and software engineering services company focused on the federal government. Its filings offer detailed information on contracts, financial results, corporate governance, and other material events.
Castellum uses Form 8-K current reports to announce significant developments, such as major contract awards to its Specialty Systems, Inc. subsidiary, participation in the Missile Defense Agency SHIELD Multiple Award IDIQ contracts, attendance at investor conferences, capital markets transactions, and changes in executive roles. For example, recent 8-K filings reference recompete and new prime contracts with the Naval Air Warfare Center Aircraft Division Lakehurst, a reseller agreement for AI-based cybersecurity products, and updates on warrant exercises and debt reduction.
Investors can also look to Castellum’s Form 10-K annual reports and Form 10-Q quarterly reports (referenced in its press releases) for broader discussions of revenue, operating results, risk factors, and segment-level information related to its cybersecurity, electronic warfare, and software engineering activities. These periodic reports complement the event-driven 8-K filings by providing a more comprehensive view of the company’s operations and financial condition.
On Stock Titan, CTM filings are paired with AI-powered summaries designed to explain the key points of lengthy documents in plain language. Users can quickly understand the significance of new 8-Ks, 10-Qs, and 10-Ks without reading every page, while still having direct access to the full text on EDGAR. The filings page also helps users monitor items such as executive employment arrangements and other governance-related disclosures that appear in Castellum’s current reports.
Castellum, Inc. (CTM) insider Form 4: A reporting person who is a Director, 10% Owner, and Officer (General Counsel, Secretary; EVP - Strategy) reported open‑market sales of common stock. The transactions were 60,000 shares on 11/11/2025 at $1.18 and 160,000 shares on 11/13/2025 at $1.165. Following these sales, the insider directly beneficially owns 7,523,973 shares.
Castellum, Inc. (CTM) reported an administrative update: the company completed a $2 million paydown and retired its note payable to Robert Eisiminger.
The update was disclosed under Other Events and includes a press release as Exhibit 99.1. This action removes that specific note obligation from the balance sheet.
Castellum, Inc. (CTM) reported an insider equity award. Chief Financial Officer David T. Bell received 225,000 stock options on November 11, 2025 under the Second Amended 2021 Stock Incentive Plan. The options have a $1.19 exercise price and expire on November 10, 2032. They vest ratably over twenty months, beginning December 1, 2025.
Castellum (CTM) reported an insider equity grant. Chief Operating Officer Andrew Merriman was awarded 275,000 stock options on November 11, 2025 under the Second Amended 2021 Stock Incentive Plan at an exercise price of $1.19 per share. The options vest ratably over twenty months, beginning December 1, 2025, and expire on November 10, 2032. Following the grant, 275,000 derivative securities are beneficially owned directly.
Castellum, Inc. (CTM) reported a director equity grant. On 11/11/2025, director C. Thomas McMillen was granted 100,000 stock options with an exercise price of $1.19 per share under the Second Amended 2021 Stock Incentive Plan.
The options relate to 100,000 shares of common stock, vesting ratably over twenty months commencing December 1, 2025, and expiring on 11/10/2032. Following the grant, 100,000 derivative securities were beneficially owned, held directly. The filing classifies the transaction as an acquisition of derivative securities as compensation for board service.
Castellum, Inc. (CTM) disclosed an insider equity award. Director Bernard S. Champoux was granted 100,000 stock options on 11/11/2025 with an exercise price of $1.19 per share under the Second Amended 2021 Stock Incentive Plan. The options vest ratably over twenty months starting December 1, 2025 and expire on 11/10/2032. The filing lists ownership as Direct (D). This is a routine compensation grant to a board member, not an open‑market purchase or sale.
Castellum, Inc. (CTM) reported an insider equity award. Director Mark S. Alarie received a grant of 100,000 stock options on 11/11/2025 under the Second Amended 2021 Stock Incentive Plan. The options have an exercise price of $1.19 per share and an expiration date of 11/10/2032.
The award was granted as compensation for service on the Board and vests ratably over 20 months starting December 1, 2025. Following the transaction, Mr. Alarie beneficially owned 100,000 stock options, held directly. The option grant price was recorded at $0 as an award (no purchase cost at grant).
Castellum, Inc. (CTM)Glen R. Ives received an equity award. On November 11, 2025, he was granted 500,000 stock options with an exercise price of $1.19 per share under the Second Amended 2021 Stock Incentive Plan. The options cover the right to purchase 500,000 shares of common stock, vesting ratably over twenty months starting December 1, 2025, and expiring November 10, 2032.
Castellum, Inc. (CTM)100,000 stock options granted on November 11, 2025 under the Second Amended 2021 Stock Incentive Plan at an exercise price of $1.19 per share.
The options are exercisable for 100,000 shares of common stock, vesting ratably over twenty months starting December 1, 2025, and carry an expiration date of November 10, 2032. The grant price for the derivative security is listed as $0 at issuance, and the ownership form is direct.
CTM holder filed a Form 144 to sell up to 800,000 shares of common stock with an aggregate market value of $1,016,000, through First Georgetown Securities, with an approximate sale date of 11/11/2025 on the NYSE.
The shares were acquired on 06/12/2019 via a merger/consolidation. In the past three months, a seller named Jay Wright reported selling 1,279,700 common shares for $1,400,305 in gross proceeds.